RG

Redmile Group Portfolio holdings

AUM $1.03B
1-Year Est. Return 108.56%
This Quarter Est. Return
1 Year Est. Return
+108.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$940M
AUM Growth
-$118M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
57
New
Increased
Reduced
Closed

Top Buys

1
+$15.5M

Top Sells

1
+$47.8M
2
+$16.6M
3
+$12.7M
4
BSX icon
Boston Scientific
BSX
+$11.6M
5
KRYS icon
Krystal Biotech
KRYS
+$10.2M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VERV
26
DELISTED
Verve Therapeutics
VERV
$8.31M 0.88%
740,261
-466,903
CBLL
27
CeriBell Inc
CBLL
$476M
$8.15M 0.87%
435,239
KROS icon
28
Keros Therapeutics
KROS
$532M
$7.38M 0.79%
552,506
CLDX icon
29
Celldex Therapeutics
CLDX
$1.74B
$6.98M 0.74%
343,026
-247,149
FOLD icon
30
Amicus Therapeutics
FOLD
$2.95B
$6.81M 0.73%
1,188,998
-8,344,671
NUVB icon
31
Nuvation Bio
NUVB
$1.6B
$5.91M 0.63%
3,031,009
ESTA icon
32
Establishment Labs
ESTA
$1.9B
$5.83M 0.62%
136,495
-198,871
PRME icon
33
Prime Medicine
PRME
$632M
$5.12M 0.55%
2,074,350
RAPT icon
34
RAPT Therapeutics
RAPT
$808M
$5.05M 0.54%
630,686
-178,729
PEN icon
35
Penumbra
PEN
$11.1B
$4.83M 0.51%
18,818
-4,025
STTK icon
36
Shattuck Labs
STTK
$125M
$4.39M 0.47%
5,539,724
ATRA icon
37
Atara Biotherapeutics
ATRA
$94.5M
$3.41M 0.36%
441,701
IGMS
38
DELISTED
IGM Biosciences
IGMS
$3.31M 0.35%
2,952,131
LVTX icon
39
LAVA Therapeutics
LVTX
$43.7M
$2.74M 0.29%
2,074,372
VTYX icon
40
Ventyx Biosciences
VTYX
$696M
$2.39M 0.25%
1,114,529
-455,264
RPTX icon
41
Repare Therapeutics
RPTX
$91.5M
$2.2M 0.23%
1,586,174
-298,215
XERS icon
42
Xeris Biopharma Holdings
XERS
$1.21B
$2.11M 0.22%
451,099
PLRX icon
43
Pliant Therapeutics
PLRX
$104M
$1.89M 0.2%
1,632,577
-420,982
IVVD icon
44
Invivyd
IVVD
$690M
$1.63M 0.17%
2,285,320
ALXO icon
45
ALX Oncology
ALXO
$85.7M
$1.41M 0.15%
3,391,455
-249,379
BOLD
46
Boundless Bio
BOLD
$27.3M
$595K 0.06%
589,034
-136,170
FDMT icon
47
4D Molecular Therapeutics
FDMT
$650M
$416K 0.04%
112,168
-885,067
KLRS
48
Kalaris Therapeutics
KLRS
$103M
$221K 0.02%
82,955
IMVT icon
49
Immunovant
IMVT
$4.24B
– –
-490,394
IRTC icon
50
iRhythm Technologies
IRTC
$5.36B
– –
-56,844
1
2
3